Franczyk, B.; Rysz, J.; Miłoński, J.; Konecki, T.; Rysz-Górzyńska, M.; Gluba-Brzózka, A.
Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19? Pharmaceuticals 2022, 15, 739.
https://doi.org/10.3390/ph15060739
AMA Style
Franczyk B, Rysz J, Miłoński J, Konecki T, Rysz-Górzyńska M, Gluba-Brzózka A.
Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19? Pharmaceuticals. 2022; 15(6):739.
https://doi.org/10.3390/ph15060739
Chicago/Turabian Style
Franczyk, Beata, Jacek Rysz, Jarosław Miłoński, Tomasz Konecki, Magdalena Rysz-Górzyńska, and Anna Gluba-Brzózka.
2022. "Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?" Pharmaceuticals 15, no. 6: 739.
https://doi.org/10.3390/ph15060739
APA Style
Franczyk, B., Rysz, J., Miłoński, J., Konecki, T., Rysz-Górzyńska, M., & Gluba-Brzózka, A.
(2022). Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19? Pharmaceuticals, 15(6), 739.
https://doi.org/10.3390/ph15060739